Status:
COMPLETED
Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer
Lead Sponsor:
Asan Medical Center
Conditions:
Cervical Cancer
Eligibility:
FEMALE
20-65 years
Brief Summary
Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence imaging for the screening of cervical cancer
Detailed Description
1. Perform pelvic vaginal exam of the subjective to know symptom, illness history, physical exam and basal state before fluorescence colposcopy. 2. Observe acetowhite epithelium and perform biopsy at ...
Eligibility Criteria
Inclusion
- age : 20-65 years
- abnormal cervical papanicolaou smear , no other specific cervical disease
- subject to colposcopic biopsy or LEEP
- signed voluntarily to informed concents with full knowledge after explanation abot objective, method, contents
Exclusion
- pregnant women
- porphyria
- severe cervical bleeding
- genital chlamydia, gonorrhea infection
- other drug user with possible interaction (e.g. photosensitizer)
- no informed consent
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01854983
Start Date
May 1 2013
End Date
April 1 2014
Last Update
May 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, South Korea, 138-736